Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/8e/18/68/8e1868dc-f19d-0a3b-5c97-f0aceede2b43/mza_15123957094614483735.jpg/600x600bb.jpg

Ori Spotlight

Ori Biotech

49 episodes

46 minutes ago

Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect

Life Sciences

Science

RSS

All content for Ori Spotlight is the property of Ori Biotech and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/14589339/14589339-1730796512575-8571329629c39.jpg

Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access

Ori Spotlight

33 minutes 7 seconds

1 year ago

Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Boro Dropulić, CEO of Vector Biomed and Executive Director at Caring Cross.

Boro shares his vision of how decentralized manufacturing, low-cost vector production, and open-source workflows can make cell and gene therapies more accessible worldwide. They also discuss the role of digital technologies, partnerships, and innovative processes in overcoming industry bottlenecks, driving down costs, and expanding this access.

Learn more about Boro on LinkedIn